glp-1 news updates november 2025 supply shortage ISPOR 2025: Exploring reasons for discontinuation GLP-1 Drugs Driving Protein Demand – Wegovy maker Novo Nordisk makes

Patients should speak with a medical provider before using any GLP-1, GIP/GLP-1, or future triple-agonist medication

Setup The first drug in a class known as GLP-1 agonists was approved in 2005 to treat diabetes

In addition, Semaglutide, another long-acting GLP-1 RA, has demonstrated superior efficacy in lowering blood glucose levels and reducing body weight compared to placebo or Liraglutide

Monitor your blood pressure regularly, especially if you have risk factors

This stands apart from u003ca href=u0022#How-Does-Gentle-Patches-Compareu0022u003elegitimate GLP-1 care,u003c/au003e where FDA-approved medications are paired with professional guidance